JP2023516709A5 - - Google Patents

Info

Publication number
JP2023516709A5
JP2023516709A5 JP2022552870A JP2022552870A JP2023516709A5 JP 2023516709 A5 JP2023516709 A5 JP 2023516709A5 JP 2022552870 A JP2022552870 A JP 2022552870A JP 2022552870 A JP2022552870 A JP 2022552870A JP 2023516709 A5 JP2023516709 A5 JP 2023516709A5
Authority
JP
Japan
Prior art keywords
gene
ep402r
ep153r
dp148r
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022552870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516709A (ja
Filing date
Publication date
Priority claimed from GBGB2003292.6A external-priority patent/GB202003292D0/en
Priority claimed from GBGB2003289.2A external-priority patent/GB202003289D0/en
Priority claimed from GBGB2005880.6A external-priority patent/GB202005880D0/en
Priority claimed from GBGB2005878.0A external-priority patent/GB202005878D0/en
Priority claimed from GBGB2013541.4A external-priority patent/GB202013541D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/050560 external-priority patent/WO2021176234A1/en
Publication of JP2023516709A publication Critical patent/JP2023516709A/ja
Publication of JP2023516709A5 publication Critical patent/JP2023516709A5/ja
Pending legal-status Critical Current

Links

JP2022552870A 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン Pending JP2023516709A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB2003292.6 2020-03-06
GBGB2003292.6A GB202003292D0 (en) 2020-03-06 2020-03-06 Vaccine
GBGB2003289.2A GB202003289D0 (en) 2020-03-06 2020-03-06 Vaccine
GB2003289.2 2020-03-06
GB2005880.6 2020-04-22
GB2005878.0 2020-04-22
GBGB2005880.6A GB202005880D0 (en) 2020-04-22 2020-04-22 Vaccine
GBGB2005878.0A GB202005878D0 (en) 2020-04-22 2020-04-22 Vaccine
GB2013541.4 2020-08-28
GBGB2013541.4A GB202013541D0 (en) 2020-08-28 2020-08-28 Vaccine
PCT/GB2021/050560 WO2021176234A1 (en) 2020-03-06 2021-03-05 Vaccine against african swine fever virus infection

Publications (2)

Publication Number Publication Date
JP2023516709A JP2023516709A (ja) 2023-04-20
JP2023516709A5 true JP2023516709A5 (https=) 2024-03-11

Family

ID=74870840

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022552880A Pending JP2023516713A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン
JP2022552870A Pending JP2023516709A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022552880A Pending JP2023516713A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン

Country Status (13)

Country Link
US (3) US20240293525A1 (https=)
EP (3) EP4114454A1 (https=)
JP (2) JP2023516713A (https=)
KR (2) KR20230013016A (https=)
CN (3) CN115397463A (https=)
AU (2) AU2021229654A1 (https=)
BR (2) BR112022016893A8 (https=)
CA (2) CA3170043A1 (https=)
CL (2) CL2022002412A1 (https=)
CO (2) CO2022014152A2 (https=)
MX (2) MX2022010373A (https=)
PH (2) PH12022552084A1 (https=)
WO (3) WO2021176235A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201910794D0 (en) * 2019-07-29 2019-09-11 Pirbright Inst Vaccine
CN120282794A (zh) * 2022-08-04 2025-07-08 T·马尔科姆 针对非洲猪瘟病毒的猪的预防和感染后治疗的显性负性抗原方法
WO2024057048A1 (en) * 2022-09-12 2024-03-21 Consejo Superior De Investigaciones Científicas Attenuated african swine fever virus and use thereof in vaccine compositions
WO2024110451A1 (en) * 2022-11-22 2024-05-30 Intervet International B.V. Attenuated african swine fever virus and use thereof in vaccine compositions
WO2024110453A1 (en) * 2022-11-22 2024-05-30 Gold Standard Diagnostics Madrid, S.A. Method for differentiating asfv infected from asfv vaccinated animals
CN117224669B (zh) * 2023-07-31 2024-07-30 中国农业科学院兰州兽医研究所 非洲猪瘟病毒mgf360-21r蛋白作为免疫诱导剂或者佐剂的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015091322A1 (en) * 2013-12-18 2015-06-25 Boehringer Ingelheim Vetmedica Gmbh Cd2 deficient african swine fever virus as live attenuated or subsequently inactivated vaccine against african swine fever in mammals
GB201410971D0 (en) * 2014-06-19 2014-08-06 Pirbright Inst The Vaccine
US9528094B2 (en) * 2014-11-10 2016-12-27 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated African swine fever virus vaccine based in the deletion of MGF genes
CN110551695A (zh) * 2019-08-14 2019-12-10 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 非洲猪瘟病毒四基因缺失弱毒株及其应用

Similar Documents

Publication Publication Date Title
JP2023516709A5 (https=)
Streicher Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics
JP2023516713A5 (https=)
Mühlberg et al. Renaissance of vancomycin: Approaches for breaking antibiotic resistance in multidrug-resistant bacteria
JP2022051775A5 (https=)
JP2019508045A5 (https=)
JP2019531763A5 (https=)
JP5873808B2 (ja) ウイルス、バクテリア、寄生生物に感染した細胞及び／又は腫瘍細胞に影響を及ぼす生物学的有効分子群、及び該分子群を適用するための方法
Schmitt et al. Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells
Yew et al. Toxicity of cationic lipid‐DNA complexes
JP2018521643A5 (https=)
US6660264B1 (en) Treatment of intracellular infection
JP2013517226A5 (ja) ウイルス、バクテリア、寄生生物に感染した細胞及び／又は腫瘍細胞に影響を及ぼす生物学的有効分子群、及び該分子群を適用するための方法
Bajaj et al. Advancements in the treatment of homozygous familial hypercholesterolemia
Lee et al. In vivo LNP-CRISPR approaches for the treatment of hemophilia
Russo et al. Life on the battlefield: valproic acid for combat applications
JP2021500409A5 (https=)
Vasukutty et al. Navigating latency-inducing viral infections: therapeutic targeting and nanoparticle utilization
JP2021515042A (ja) ムチンに作用するプロテアーゼを含む製剤
JP2021512929A5 (https=)
HRP20231299T1 (hr) Inhibitori pi3k p-delta 110 za uporabu u isporuci virusa u liječenju raka
Levi et al. Precision medicine trials in retinal degenerations
Tekintaş et al. Antisense oligonucleotides: a promising therapeutic option against infectious diseases
Machitani et al. Inhibition of CRISPR/Cas9-mediated genome engineering by a type I interferon-induced reduction in guide RNA expression
Tsao et al. Paired trial of cyclophosphamide and prednisone in children with nephrosis